Works matching AU We


Results: 1075
    1
    2
    3
    4
    5

    Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clinically selected population excluding patients with non-smoking adenocarcinoma or mutated EGFR.

    Published in:
    2015
    By:
    • Yoon Ji Choi;
    • Dae Ho Lee;
    • Chang Min Choi;
    • Jung Shin Lee;
    • Seung Jin Lee;
    • Jin-Hee Ahn;
    • Sang-We Kim;
    • Choi, Yoon Ji;
    • Lee, Dae Ho;
    • Choi, Chang Min;
    • Lee, Jung Shin;
    • Lee, Seung Jin;
    • Ahn, Jin-Hee;
    • Kim, Sang-We
    Publication type:
    journal article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    16
    17
    18
    19
    20
    21
    22
    23

    Parental worries and beliefs about abdominal pain.

    Published in:
    2009
    By:
    • van Tilburg MA;
    • Chitkara DK;
    • Palsson OS;
    • Levy RL;
    • Whitehead WE;
    • van Tilburg, Miranda A L;
    • Chitkara, Denesh K;
    • Palsson, Olafur S;
    • Levy, Rona L;
    • Whitehead, William E
    Publication type:
    journal article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer.

    Published in:
    Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae356
    By:
    • Skoulidis, Ferdinandos;
    • Li, Bob T;
    • Hochmair, Maximilian;
    • Govindan, Ramaswamy;
    • Vincent, Mark;
    • Wekken, Anthonie J van der;
    • Aransay, Noemi Reguart;
    • O'Byrne, Kenneth J;
    • Girard, Nicolas;
    • Griesinger, Frank;
    • Nishio, Makoto;
    • Häfliger, Simon;
    • Lindsay, Colin;
    • Reinmuth, Niels;
    • Paulus, Astrid;
    • Papakotoulas, Pavlos;
    • Kim, Sang-We;
    • Ferreira, Carlos Gil;
    • Pasello, Giulia;
    • Duruisseaux, Michael
    Publication type:
    Article
    44

    Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21.

    Published in:
    Oncologist, 2015, v. 20, n. 12, p. 1440, doi. 10.1634/theoncologist.2015-0128
    By:
    • Kim, Hyo Jung;
    • Shin, Sang Won;
    • Song, Eun‐Kee;
    • Lee, Na‐Ri;
    • Kim, Jun Suk;
    • Ahn, Jin Seok;
    • Yun, Hwan‐Jung;
    • Cho, Yo‐Han;
    • Park, Keon Uk;
    • Kim, Si‐Young;
    • Jang, Joung Soon;
    • Kim, Sang‐We;
    • Lee, Hyun Woo;
    • Lee, Se Ryeon;
    • Kim, Yang Soo;
    • Lee, Soon Nam;
    • Ko, Yoon Ho;
    • Kim, Hwa Jung;
    • Kang, Jin‐Hyoung
    Publication type:
    Article
    45
    46
    47
    48
    49
    50